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Abstract
Background: Home fortification using sachets of micronutrient powder (e.g. “Sprinkles”) is a food-based approach
offering an alternative to high dose vitamin A (VA) supplements for infants. The primary objective was to
investigate the impact of VA-home fortification on infant VA pool size. The secondary objective was to compare VA
status of infants assessed by the modified relative dose response (MRDR) test before and the 13C-retinol isotope
dilution (13C-RID) test in the same infants after vitamin A supplementation.
Methods: A randomized-controlled trial was conducted in 7–9 month old infants in Ghana. Eligible children were
randomly allocated to receive a daily sachet of “Sprinkles” with or without VA for 5 months added to complementary
foods. The MRDR test indirectly determined VA liver reserves at baseline and the 13C-RID determined VA body pool at
follow-up in the same cohort of children.
Results: At baseline, the MRDR values (95 % CI) for infants were comparable in the intervention and control groups:
normal at 0·032 (SD 0·018) (0·025–0·038) and 0·031 (SD 0·018) (0·024–0·038), respectively. After intervention,
total body stores (TBS) and liver retinol concentrations did not differ between intervention and control
groups; TBS were 436 (SD 303) and 434 (SD 186) μmol, respectively, and estimated liver concentrations were
0·82 (SD 0·53) and 0·79 (SD 0·36) μmol/g liver, indicating adequate reserves in all children.
Conclusions: Both the MRDR and 3C-RID tests confirmed that the infants had adequate VA status before and after home
fortification of their complementary foods. These tests offered more information than serum retinol concentrations alone,
which predicted VA deficiency using current suggested cutoffs not corrected for inflammation status.
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Background
The growth rate of breast-fed infants in developing
countries during the first 6 months of life is comparable
to that of infants in developed countries. However,
infants in developing countries deviate from this satis-
factory growth pattern after this period [1]. This has
been attributed to lack of nutrient-dense complemen-
tary foods and is further exacerbated by persistent
micronutrient deficiencies [2] thus making children in
developing countries vulnerable to diseases and death
during the weaning period. One means of addressing
this problem in poor communities where infants and
young children consume monotonous cereal-based di-
ets, is by feeding infants complementary foods con-
taining micronutrients, such as vitamin A (VA), iron
and zinc sprinkled on the food immediately before
feeding [3–5].
Vitamin A deficiency is a public health problem in many
countries and diminishes the ability of young infants to
fight infections predisposing them to an increased risk of
early death [6]. Infections occurring during the infant’s life
lead to increased risk of morbidity [7, 8], VA excretion in
urine, and increased VA requirements [9]. High dose
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supplements are an effective way to ward off the deleteri-
ous effects of VA deficiency [10], and reduce mortality
[11] and severe morbidity [12, 13] in children 1–5 y of age
in less developed countries. Children are born with low
VA stores and depend on their mother’s milk for VA. Be-
fore an infant is introduced to complementary foods, the
mother may not be able to provide enough VA to boost
the child’s liver stores if she herself has low VA stores [14]
or does not consume rich sources of VA during lactation.
Home fortification is a food-based approach offering
an alternative to administration of high dose VA supple-
ments directly to infants and young children [3]. A novel
practical formulation of micronutrient powders in single
dose sachets, commonly called “Sprinkles”, was devel-
oped for home fortification of weaning foods to address
the problem of micronutrient deficiency in young in-
fants. “Sprinkles” can be added once daily to any com-
plementary food immediately before serving. Sachets
typically contain iron and zinc; vitamins A, C, and D;
and folic acid [15]. Sprinkles can be used to meet the in-
fants’ high VA requirements for rapid growth after
6 months of age [15–17].
The success of home-based strategies needs to be eval-
uated by assessing VA status [18]. Serum retinol con-
centrations, which are homeostatically controlled yet
depressed during times of infection due to the acute
phase response [19, 20], are only useful when liver re-
serves are severely depleted but many children suffer
from a marginal VA status [21]. The modified relative
dose response (MRDR) test indirectly determines VA
liver reserves. As liver VA reserves become depleted,
apo-retinol-binding protein accumulates in the liver. A
challenge dose of 3,4-didehydroretinyl acetate is admin-
istered and the response of 3,4-didehydroretinol (DR)-
holo-retinol-binding protein complex is measured in the
serum ~5 h after dosing [21–23]. The MRDR test is a
categorical indicator of VA status and is typically posi-
tive at <0.1 μmol retinol/g liver [21]. The MRDR test
distinguishes between moderately inadequate and ad-
equate VA status, based on the ratio of DR to retinol
(DR:R) in serum after dosing [24]. Stable isotopes are
used to determine the VA body pool by using deuterium
or 13C-retinol as a tracer [25, 26]. The tracer dilution
technique is the only indirect measure that provides a
quantitative estimate of total body VA pool size [27] and
stable isotopes lack the potential deleterious effects of
radioisotopes on human health [28].
The primary objective of this study was to investigate
the impact of VA-home fortification on infant VA pool
size using the 13C-retinol isotope dilution (13C-RID) test
at follow-up among children who received “Sprinkles”
with or without VA added to complementary foods. VA
status of infants was determined at baseline with the
MRDR test because it requires a smaller volume of
blood and is less expensive to analyse than the 13C-RID
test. Thus, although the two methods were not used
concurrently at baseline and endline, the secondary ob-
jective was to use the MRDR test and the 13C-RID test
in the same cohort of infants because this has not been
done before.
Methods
Study site
The trial was carried out in 7 villages surrounding
Kintampo located in the Brong Ahafo Region of Ghana.
The district has a resident population of about 140,000,
the majority of whom have a relatively poor socioeco-
nomic status [29]. Anthropometric data also indicated a
prevalence of stunting of 32 % and wasting of 4 %
among children aged 12 months [30].
Participants and study interventions
This community-based study included infants aged 7–9
months (n 93) and their ages were verified by inspecting
their vaccination cards. Children of this age were se-
lected to ensure that weaning had been established after
they were identified by trained field workers. Eligible
children were enrolled at home and randomly allocated
to receive daily “Sprinkles” with or without VA using a
computer generated random number table. Eligibility
criteria included willingness of mothers to provide con-
sent, to stay in the study area throughout the study dur-
ation and to feed the child with the contents of the
micronutrient sachets. The child was also expected to
eat complementary foods in addition to breast milk, and
haemoglobin needed to be >70 g/l. Those in the VA
group received a daily dose of a powdered fortificant
(MNP-Sprinkles; Mumbai, India) containing 12 · 5 mg of
elemental iron (as microencapsulated ferrous fumarate)
plus ascorbic acid (30 mg), retinyl palmitate (400 μg
RAE), and zinc (5 mg). The control group received a
similar fortificant that did not contain VA. Blinding of
the intervention was carried out by a neutral group of
persons who packaged the supplements in identical
packages with codes unknown to the investigators. Field
workers delivered weekly supplements to mothers for
use 7 d/week. At the conduct of this trial, VA supple-
mentation was a national policy given to infants when
they reached 6 months of age through national cam-
paigns. Children enrolled in this study were excluded
from taking the routine VA supplementation until the
end of the 5-month study by marking their vaccination
cards stating that they were enrolled in another study
and should not be given routine VA supplementation at
6 months of age as is the practice in Ghana. This was
effectively ensured by inspecting the identity cards of all
children enrolled to determine if they were part of any
other ongoing studies or programs that routinely
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administer VA supplementation. Infants were followed
for 5 months. Mothers were instructed to mix a single
sachet of “Sprinkles” with a small amount of food and to
add water and sugar as needed to ensure that the child
consumed the entire sachet. Breast feeding is universal
in this area and mothers were not prevented from breast
feeding their infants during the intervention. Where
there were two eligible children in a household, only one
was randomly selected. This was done to prevent con-
tamination if it happened that the two children belonged
to different groups and they happened to share food
with each other.
Sample size
Sample size was based on previous stable isotope work
done by Tondeur et al. [31] in Kintampo. We estimated
that 15 infants per group would be sufficient to detect a
5 % difference in VA pool size with a 5 % SD on the
basis of a type 1 error set at 0·05 and a 0·8 probability of
detecting a true difference between the two groups. Inci-
dentally, at the time this study was performed, fifteen
children per group was considered adequate for the de-
termination of the VA body pool size for supplements as
stated by the Vitamin A Tracer Task Force [27]. The pri-
mary objective served as the basis for the sample size
calculation but the sample size requirements for the
MRDR test to be descriptive of the VA status as stated
by the Vitamin A Tracer Task Force [27] was larger and
hence the need for more children to be recruited.
Study procedures
A detailed explanation of the purpose, risks, and benefits
were verbally explained and consent was sought for chil-
dren’s participation from their mothers. In the presence
of a witness, mothers who were literate signed a consent
form but fingerprints were obtained for those who could
not sign. The child of each consenting mother was
issued a study ID card containing identification informa-
tion, which was used by trained staff to replenish their
weekly supply of Sprinkles and for database manage-
ment. Information on compliance was obtained by col-
lecting the used empty sachets weekly from mothers and
because the study was double-blind, compliance was ex-
pected to be similar in both groups; however, the alloca-
tion of the empty sachets were not verified to determine
which group they belonged to in order not to disclose
the groups to which the children had been assigned.
All information collected was considered confidential
and was de-identified. The Institutional Ethics Committee
of the Kintampo Health Research Centre (Office for
Human Research Protections Federal Wide Assurance
Number 00011103 and IRB registration number 0004854)
approved the study protocol. The study was registered
with clinical trials.gov NCT 01751009.
Information was collected on socioeconomic status
(occupation), marital, and education status. Morbidity
questionnaires were used to collect health data by
fieldworkers for the 5 months through surveillance fort-
nightly, the health of the child was assessed and infor-
mation was collected on whether the child had been
taken to a health facility within the past two weeks. At
the beginning and end of the 5 months study period,
anthropometric, haemoglobin [32], CRP [33] (QuickRead,
Orion Diagnostica, Finland), and ferritin (Spectro Ferritin,
Ramco Laboratories USA) [34, 35] assessments were
carried out. Haemoglobin concentrations were measured
with the use of a portable HEMOCUE-Hemoglobin
photometer (Hemocue Inc, Angelholm, Sweden). Haemo-
globin was considered low if <100 g/l [36]. Depleted iron
stores were defined as ferritin < 12 μg/l and elevated CRP
was defined as >5 mg/L.
Modified relative dose response test
The MRDR test involved giving an oral dose of 5 · 3 μmol
3,4-didehydroretinyl acetate dissolved in 290 μl corn oil
in the morning using a 0 · 3 ml insulin syringe. The
children were dosed at their homes and 5 h later a heel
prick blood sample (~500 μl) was taken. The samples
were stored on ice away from light in a cooler until
transported to the laboratory. Clotted blood samples
were centrifuged at 600 X g for 10 min and the serum
was stored at –20 °C until shipped. After completion of
the trial, samples were shipped frozen to the Vitamin A
Assessment Laboratory at University of Wisconsin-
Madison. All samples arrived frozen and were immedi-
ately stored at -80 °C until analysis. The samples were
analysed for DR and R using a standardised method de-
veloped specifically for small serum volumes [37].
MRDR values (DR:R) >0 · 06 were used to indicate VA
deficiency.
Extraction and high-pressure liquid chromatography
(HPLC) procedures
The standard HPLC method was followed as published
for 200 μl serum [37] except three extractions were
made with 300 μl hexanes instead of two [38].
Description of 13C-retinol isotope dilution test
Blood samples of 7 children from both groups were ran-
domly taken in May 2010 after the last sachets were
used to serve as a measure of natural abundance of 13C
[39]. The remaining [33] children (14 VA group; 19
control) were given an oral 1 μmol (288 μg retinol
equivalents) dose of 13C2-retinyl acetate followed by 14
d to allow for tracer mixing with the retinol pool in
children [40, 41]. Blood (2 ml) was collected from 33
infants for assessment of the VA liver stores and results
were obtained for 24 infants because insufficient serum
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was obtained from some infants. The optimal amount of
serum required for the test is 1 · 5 ml, although we were
able to get reliable readings on 0 · 5 ml. The samples were
analysed using the method of Howe et al. [39] modified by
Valentine et al. [42]. The gas chromatography/combustion/
isotope ratio mass spectrometer was run as previously
described by Howe et al. [39].
Calculation of total body vitamin A stores
Total body VA was calculated using the following mass
balance equation, substituting for c, and rearrangement:
Fax að Þ þ Fbx bð Þ ¼ Fcx cð Þ
c ¼ a þ b
b ¼ a Fa− Fcð Þ = Fb− Fcð Þ
Where Fa = atom percent (%At) of the dose*0 · 01 = 0 · 1
(2 of 20 atoms labeled), Fb = %At at baseline*0 · 01
based on the mean of natural enrichment samples,
and Fc = %At at day 14 after dosing*0 · 01 (%At for
each of the individual results). Additionally, a = μmol
VA absorbed from the dose, which is assumed to be
80 % in this group of infants who are susceptible to mul-
tiple infections [41, 43], b = uncorrected body pool at
baseline (unknown), and c = μmol VA in body pool after
dosing = a + b. It is then corrected for loss of tracer in the
body over the 14 d by accounting for the half-life of ret-
inol in young children [44], so the corrected body pool of
VA = b x e^(-kt) where k = ln(2)/32 and t = time in days of
the serum collection after the dose was administered.
Finally, the total body stores (TBS) were corrected for the
serum to liver ratio of 0 · 8 because the infants were not
fed a low-VA containing diet during the equilibration
period, which is supported by one human study [45].
Total liver reserves were assumed to be 80 % of TBS and
liver weight was assumed to be 4 % of total body weight in
these infants [43, 46]. Of the 14 completing children in
the intervention group who were actually tested using
stable isotopes, 10 were males and 4 were females, and for
the 19 in the control group, 7 were males and 12 were
females.
Data management and statistical analyses
Field supervisors checked all forms manually for complete-
ness. Forms were double entered on computers, range and
consistency checks performed, and discrepancies resolved
with reference to the original form using Microsoft Visual
Foxpro version 9 · 0 Data Management Software. Data
were analysed using Stata version 11. Simple descriptive
analysis of baseline measures (e.g. demographic, socioeco-
nomic, biochemical) was performed across the treatment
groups to confirm their comparability. Categorical demo-
graphic characteristics were summarised as proportions,
while continuous variables were summarised as means.
Differences in means of quantitative variables, such as fer-
ritin, MRDR, and CRP, between intervention and controls
at baseline and endline were evaluated using t-tests. Nor-
mality of residuals for isotopic data was assessed by the
Shapiro-Wilk test. Non-parametric analysis was carried
out on ranked data. Anthropometric indices of height-for-
age (HA), weight-for-age (WA), and weight-for-height
(WH) were expressed as z-scores using the WHO Anthro
for personal computers, Version 3 · 1, 2010. P < 0 · 05 was
considered statistically significant.
Results
Enrolment of subjects
The studied children were enrolled from January
through June 2010. There were 30/47 (63 · 9 %) males in
the intervention group and 19/46 (41 · 3 %) in the con-
trol group. Characteristics of mothers of children in both
groups were similar (Table 1). Seven infants were lost to
follow-up before blood samples could be collected for
VA analyses leaving 86 eligible children (Fig. 1). Ten
mothers moved out of the study area during the farming
season, a mother reported that her child was sick and
three mothers refused to allow blood samples of their
infants to be collected. Blood samples were collected
from a total of 72 children for haemoglobin analyses.
Vitamin A status in infants
Out of 93 children enrolled, 63 blood samples were fi-
nally collected for MRDR testing at baseline to deter-
mine VA status. Even though 72 children were eligible,
nine infants were not presented by their mothers for the
final blood draw for the MRDR test due to suspected
concerns with blood draw. The MRDR test (n 30 and 33
in the intervention and control groups, respectively)
showed that there was no difference in the VA status be-
tween the groups even when infants with high CRP were
excluded (Table 2). At baseline, the mean ratio (95 % CI)
of MRDR for infants in the intervention group repre-
sented sufficient vitamin A status 0 · 032 (0 · 025–0 · 038)
(SD 0 · 018), values did not differ from those of the con-
trol group, i.e., 0 · 031 (0 · 024–0 · 038) (SD 0 · 018). In
contrast, the mean serum retinol concentrations were
0 · 812 (SD 0 · 238) (95 % CI 0.73–0.90) and 0 · 781
(SD 0 · 266) (95 % CI 0.69–0.87) μmol/L for the inter-
vention and control groups, respectively, with 34.9 %
of the children having a serum retinol concentration
below 0 · 7 μmol/L, which is used as a cutoff value for VA
deficiency. The MRDR and serum retinol concentrations
were not correlated (r = 0.167, P = 0.19). After 5 months
supplementation, the vitamin A status was assessed as
endline on a subgroup of infants in both groups using the
13C-RID test. Liver retinol concentrations did not differ
between groups (P = 0 · 87) and all children had adequate
status. The intervention and control groups had TBS of
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436 (SD 303) and 434 (SD 186) μmol, respectively. The
estimated liver reserves were 0·82 (SD 0·53) and 0·79
(SD 0·36) μmol/g of liver for the intervention and control
groups, respectively. Even removing the results of TBS of
three potential outliers (545 – 697 μmol) out of the total
24 infants did not demonstrate a significant difference in
the liver stores and therefore they were left in the statis-
tical analysis. In this group of infants, both the MRDR and
isotope dilution tests indicated adequate liver reserves in
all children.
Anthropometry and haematological indices
Weight and height of enrolled children did not differ at
baseline and endline. There was no change observed in
other anthropometric indices between the intervention
and the control groups Table 3. The two groups were not
significantly different with respect to their anaemia and
CRP status at baseline. At the end of the supplementation
period, more infants tended to be anaemic in the control
group as compared with the intervention group (23 · 5 %
vs. 31 · 6 %) but this was not significant (Table 2).
Morbidity assessment for infants during biweekly visits
An assessment of clinical conditions was carried out
every other week from the start of supplementation until
the end of the 5 months period. There were no differ-
ences in any of the conditions assessed, but more infants
sought treatment in the intervention group compared
with the control group during weeks 12 and 14
(Table 4).
Discussion
This study explored the use of stable 13C-tracer method-
ology to assess the VA body pool size in infants who were
followed for a 5-months period of micronutrient home for-
tification with and without VA. Stable isotopes were used
because they lacked the potential harmful effects of radio-
isotopes on human health making them ideal for studying
a broad range of metabolic conditions [47]. The baseline
VA status of the children who participated was normal as
assessed by the MRDR test and the VA status remained
normal after the intervention. The mean TBS of VA also
did not differ between groups after the intervention. Serum
Table 1 Comparison of age of children and baseline data of mothers in the intervention and control groupsa
Intervention Control P
n 47 n 46
Number Percent Number Percent
Parity
1–3 26 55 · 3 26 56 · 5
4–6 14 29 · 8 12 26 · 0 0 · 09
>6 7 14 · 9 8 17 · 4
Education
None 29 61 · 7 31 67 · 4
Primary 7 14 · 9 5 10 · 9 0 · 80
Middle 8 17 · 0 7 15 · 2
Secondary 3 6.4 2 4 · 3
Unknown 0 1 2 · 1
Marital status
Married 32 68 · 1 29 63 · 0
Living together 12 25 · 5 12 26 · 0 0 · 71
Widowed 0 0 1 2 · 2
Divorced 0 0 1 2 · 2
Single unmarried 3 6 · 4 3 6 · 5
Occupation
Farmer 38 · 0 80 · 8 34 · 0 73 · 9
Trader 5 · 0 10 · 6 5 · 0 10 · 9 0 · 59
Professional 4 · 0 8 · 5 7 · 0 15 · 2
Age, months Mean Range Mean Range
Baseline 8 · 2 7 · 9–8 · 1 8 · 4 8 · 1–8 · 7 0 · 30
Endline 14 · 1 13 · 7–14 · 1 14 · 4 14 · 0–14 · 7 0 · 23
aNo significant difference was noted among treatment groups for all characteristics shown
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Fig. 1 Numbers of infants at each stage in the trial, and the reasons for any losses to follow up
Table 2 Infant vitamin A status, hematologic and anaemia indexes at baseline and end line in intervention and control groups
Intervention Control
Low vitamin A statusy Number % Number %
All infants 2/29 6 · 9 2/34 5 · 9 0 · 87
Excluding infants with high CRPd 2/22 9 · 1 2/26 7 · 7 0 · 86
Adequate vitamin A by MRDRχ
All infantsχ 27/29 93 · 1 32/34 88 · 2 0 · 86
Excluding infants with high CRPd 20/22 90 · 9 24/26 92 · 3 0 · 86
Baseline indexes Mean Mean
Haemoglobin (g/l) 103 101
Number % Number %
Prevalence of anaemiab 18/47 38 · 3 20/46 42 · 5 0 · 61
Prevalence of low ferritinc 0/32 0.0 1/34 2 · 9 0 · 33
Prevalence of elevated CRPd 7/32 21 · 9 8/34 23 · 5 0 · 87
Endline indexes Mean Mean
Haemoglobin (g/l) 111 108
Number % Number %
Prevalence of anaemiab 8/34 23 · 5 12/38 31 · 6 0 · 44
Prevalence of low ferritinc 0/16 0 · 0 0/17 0.0 -
Prevalence of elevated CRPd 8/17 47 · 0 7/17 41 · 2 0 · 73
aχ ± SD
bDefined as haemoglobin concentration <10 g/dl
cDepleted iron stores defined as ferritin < 12 μg/l
dElevated CRP > 5 mg/L
ylow vitamin A status MRDR ≥ 0 · 06
χAdequate vitamin A status MRDR < 0 · 06
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retinol concentrations were <0.7 μmol/L in 34.9 % of the
children at baseline, but this may have been due to the fact
that ~23 % of them had inflammation, which was assessed
with CRP.
The approach of using two different methods of asses-
sing vitamin A status at different times meant that it
was not possible to compare VA body pool size at any
one point using the 13C-RID test. The only option was
to compare the VA body pool size of children in the
intervention and the control group. This may have
limited our power to detect an intervention effect. For
ethical reasons, our comparative group was not a true
placebo but received other micronutrients like zinc and
iron, which are also known to enhance VA status and
could have led to the lack of an intervention effect. Zinc
is a cofactor in the β-carotene cleavage enzyme poten-
tially making the VA more bioavailable from plant
sources [48]. Zinc also is involved in the synthesis of
Table 3 Infant anthropometric status (z-scores) at baseline and end line in intervention and control groups
Intervention Control p
Baseline anthropometry Mean SD Range Mean SD Range
Child weight (kg) 7 · 6 1.03 7 · 20, 7 · 90 7 · 3 1.04 7 · 0, 7 · 60 0 · 19
Child height (cm) 68 · 2 3.19 67.3, 69.2 68 · 4 3.01 67 · 5, 69 · 3 0 · 79
Height-for-agea -0 · 8 1 · 16 -1 · 18, -0 · 50 -0 · 7 1 · 28 -1 · 09, -0 · 33 0 · 62
Weight-for-agea -1 · 0 1 · 06 -1 · 32, -0 · 69 -1 · 2 1 · 27 -1 · 60, -0 · 85 0 · 37
Weight-for-heighta -0 · 6 1 · 07 -0 · 95, -0 · 32 -1 · 1 1 · 12 -1 · 40, -0 · 72 0 · 06
Endline anthropometry
Child weight (kg) 8 · 3 1.77 7 · 70, 8 · 90 8 · 3 1.74 7 · 70, 8 · 90 0 · 95
Child height (cm) 74.1 3.30 72 · 9, 75 · 3 74 · 5 3.31 73 · 4, 75 · 6 0 · 61
Height-for-agea -1 · 4 1 · 17 -1 · 79, -0 · 95 -1.2 1 · 16 -1 · 55, -0 · 77 0 · 46
Weight-for-agea -1 · 3 0 · 89 -1 · 64, -1 · 00 -1.3 1 · 16 -1.67, -0.90 0 · 9
Weight-for-heighta -0 · 9 0 · 72 -1 · 19, -0 · 67 -1.0 1 · 21 -1.43, -0.61 0 · 7
aχ ± SD
Table 4 Comparison of morbidity reports for infants at 2 week visits between intervention and control groupsa
Intervention Control P Intervention Control P
Number Percent Number Percent Number Percent Number Percent
2 weeks 2 weeks 4 & 6 weeks 4 & 6 weeks
Cough 8/40 20 · 0 6/38 15 · 8 0 · 63 11/82 13 · 4 7/76 9 · 2 0 · 40
Diarrhoea 12/40 30 · 0 11/38 28 · 9 0 · 92 19/82 23 · 2 24/76 31 · 6 0 · 23
Refuse breast 2/40 5 · 0 0/38 0 · 0 0 · 16 4/82 4 · 9 2/76 2 · 6 0 · 46
Feverishness 5/40 12 · 5 4/38 10 · 5 0 · 78 13/82 15 · 8 15/76 19 · 7 0 · 52
Sought treatment in past 2 weeks 8/40 20 · 0 4/38 10 · 5 0 · 25 20/82 24 · 4 17/76 22 · 4 0 · 76
8 & 10 weeks 8 & 10 weeks 12 & 14 weeks 12 & 14 weeks
Cough 6/80 7 · 5 6/76 7 · 9 0 · 92 8/84 9 · 5 2/82 2 · 4 0 · 06
Diarrhoea 23/80 28 · 7 21/76 27 · 6 0 · 88 28/84 33 · 3 19/82 23 · 2 0 · 15
Refuse breast 1/80 1 · 2 3/76 3 · 9 0 · 28 0/84 0 · 0 1/82 91 · 2 0 · 31
Feverishness 19/80 23 · 7 26/76 34 · 2 0 · 15 14/84 16 · 7 8/82 9 · 8 0 · 19
Sought treatment in past 2 weeks 17/80 21.2 13/76 17.1 0.51 16/84 19.0 6/82 7.3 0.03
16 & 18 weeks 16 & 18 weeks 20 & 22 weeks 20 & 22 weeks
Cough 3/79 3 · 8 4/81 4 · 9 0 · 70 1/73 1 · 4 5/81 6 · 2 0 · 12
Diarrhoea 20/79 25 · 3 19/81 23 · 5 0 · 78 17/73 23 · 3 19/81 23 · 5 0 · 98
Refuse breast 2/79 2 · 5 2/81 2 · 5 0 · 98 1/73 1 · 4 5/81 6 · 2 0 · 12
Feverishness 15/79 18 · 9 16/81 19 · 7 0 · 90 12/73 16 · 4 23/81 28 · 4 0 · 08
Sought treatment in past 2 weeks 14/79 17 · 7 12/81 14 · 8 0 · 62 15/73 20 · 5 16/81 19 · 7 0 · 90
a% of subjects with side effects as a percentage of the total number of visits for the periods indicated
There were no reports of convulsions and bulging fontanelles
Newton et al. Archives of Public Health  (2016) 74:10 Page 7 of 10
retinol-binding protein and thus may influence transport
[49].
The VA status of young infants is known to be influ-
enced by the liver retinol stores at birth, consumption of
VA from breast milk and other foods, and losses from
infections and parasites [50]. Many infants in developing
countries remain VA deficient at 6 months of age after the
weaning period and will require additional VA [51, 52].
The present study showed that infants in the two groups
had comparable VA status as assessed by the MRDR at
baseline and 13C-RID tests at endline. The fact that there
was no difference in the vitamin A status of infants
between groups suggests that in rural communities in
Ghana, this method of home fortification did not signifi-
cantly improve the VA stores of infants in the intervention
group compared with infants in the control group over
the study period. This is likely due to the adequate VA sta-
tus observed in this study. TBS were twice as high as Thai
children who had marginal to deficient liver reserves and
had no access to fortified foods [40], and half as much as
Zambian children who had adequate to hypervitaminotic
stores of VA on the background of VA supplementation
and fortification [41]. The mean values obtained in these
Ghanaian infants (~0.8 μmol/g liver) are the same as the
midpoint of two Ghanaian infants (0.77 μmol/g liver) who
died from serious infections [53]. In 6 to 12 month old US
children, the mean value of vitamin A 0.30 ± 0.21 μmol/g
liver is lower than the assessed vitamin A values with
Ghanaian infants [54]. Ghana had many VA interventions
in place when this trial occurred including VA supple-
ments at immunisation contacts and post-partum supple-
mentation to lactating mothers, which may have been
missed on the identity cards. Furthermore, green leafy
vegetables are widely consumed [38] and vegetable oil and
wheat flour are now VA-fortified [55].
Three main strategies have been implemented for im-
proving the VA status among populations: supplementa-
tion, food fortification, and dietary diversification [56].
De Pee et al. emphasised the need for effective VA pro-
grams in poor countries to include a mix of supple-
mentation, fortification, and dietary diversification [57].
Filteau and Tomkins have advocated that the choice of
strategy is context specific and must take into account
climate, the agricultural potential of the region, local
infrastructure, food beliefs, and socioeconomic status of
the population [56]. The current study reveals that sensi-
tive VA assessment is also necessary to demonstrate
whether supplementation or fortification is needed in
target groups.
Young infants from developing countries are often VA
deficient and studies from Bangladesh and Brazil have
shown that a quarter to 90 % of children studied had in-
adequate liver stores assessed by MRDR and autopsy
samples, respectively [58]. However, studies in American
infants reported no VA deficiency in livers of 6–12
month old infants at necropsy [59]. Assessment of mor-
bidity during our trial did not reveal any difference be-
tween those who had been given Sprinkles with VA and
those whose sachets did not contain VA. This observa-
tion is similar to that found in a trial in Ghana where
children were followed weekly to ascertain the occur-
rence of morbidity. There were no significant differences
between the two arms (vitamin A and placebo) with re-
spect to diarrheal and respiratory conditions, but chil-
dren who received VA had significantly fewer clinical
visits and hospital admissions [12]. Villamor and Fawzi
have suggested that the protective effect of VA was me-
diated by a reduction in severity rather than the inci-
dence of infections [60] and this study seems to agree
with those findings even though in our study seeking
hospital care was used as a proxy for severity. In a trial
in Tanzania by Idindili et al., a clinical surveillance sys-
tem did not confer any clinically important absolute ef-
fect on morbidity [61] and this was seen in earlier trials
in Ghana in Kintampo [29] but in that trial there were
differences in all anthropometric indices between the
vitamin A and the placebo groups. The earlier study in
Ghana enrolled younger children and gave three doses
of 25,000 IU VA at 6, 10 and 14 weeks of age with
immunization compared with children in this present
study who were between the ages 7–9 months at enrol-
ment. The impact of improvements in VA status is also
likely to be related to the extent of deficiency in the
population [12, 21]. It should be noted that mothers in
the study communities had low socioeconomic status
and results of the MRDR tests conducted at baseline
showed that all infants had adequate VA status. The
mothers may have received high dose supplements post-
partum and this may have benefited the infants but no
evidence exists to confirm whether this actually hap-
pened. No evidence existed, but the infants enrolled in
the study may have received VA at their earlier im-
munization contacts. However, breast-feeding is univer-
sal and likely contributed to the adequate liver stores in
these children.
Vitamin A can be obtained from the diet as preformed
VA (retinol and its esterified form, retinyl ester) in dairy
and organ meats or as provitamin A carotenoids from
vegetable and fruits; although, it is unlikely that infants
in the study consumed much of these foods. In develop-
ing countries, 70–90 % of VA is obtained from provita-
min A carotenoids in plant foods and these are absorbed
much less efficiently (20–50 %) depending on VA status
and other non-dietary factors [48, 62]. Some of the main
staple foods in the studied area in Ghana are millet, sor-
ghum, and groundnuts, which do not contain significant
amounts of carotenoids. However, in Europe and the
United States, 75 % of dietary VA is from preformed VA
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and the fortification of foods, such as milk, breakfast ce-
reals, and some snack foods [63]. This study was not
able to do more sophisticated comparisons with the
MRDR and stable isotope dilution, such as sensitivity
and specificity, because there was a significant amount
of time in between the MRDR and isotope dilution tests.
Future comparisons of biomarkers should consider this.
Developing countries, such as Ghana, have often used
serum retinol in the assessment of VA status but stable
isotope methodology can be used, even though it is
more expensive [27], to quantitatively estimate TBS of
VA [21, 43].
Conclusions
This is the first study to assess VA status using the
MRDR test before and stable isotope dilution technique
after the intervention in the same children. Both the
MRDR and 3C-RID tests confirmed that the infants had
adequate VA status before and after home fortification
of their complementary foods. These tests offered more
information than serum retinol concentrations alone,
which indicated VA deficiency. In fact, 34·9 % of the
children were diagnosed with VA deficiency using serum
retinol at baseline, which WHO defines as a severe pub-
lic health problem. This is one of the reasons that WHO
recommends that serum retinol concentrations should
not be used alone as they are homeostatically controlled
and do not change unless VA status is deficient [64].
Due to this phenomenon, other assays, such as the MRDR
and RID tests, have been developed. In current studies
using only serum retinol concentrations to assess VA
status, it is highly recommended that CRP and α1-acid
glycoprotein be measured to correct serum retinol con-
centrations [65]. Further population-based research needs
to be conducted to determine the feasibility of using stable
isotopes to evaluate different VA interventions [66].
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